What we found on the web about Atomoxetine
Atomoxetine is a non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine ...
... no effect on other monoamine levels; recent studies suggest a phenomenology of heteroreceptor regulation in the medial prefrontal cortex; whereby NRIs (for example Atomoxetine ...
Atomoxetine is not approved for major depressive disorder; patients presenting ... Atomoxetine may increase heart rate or blood pressure in the presence of pressor ...
Atomoxetine drugs for attention deficit hyperactivity disorder. ... Atomoxetine is a drug used in psychiatry. It is indicated for the treatment of attention deficit/hyperactivity ...
The Food and Drug Administration (FDA) directed Eli Lilly (Lilly) to ... Regulatory History of Atomoxetine from Drugs@FDA. Report Adverse Events to MedWatch ...
Learn about mental health info includes addiction, anxiety, depression, food and diet, sex, stress, ... DRUG CLASS AND MECHANISM: Atomoxetine is an oral drug ...
Strattera capsules contain the active ingredient atomoxetine hydrochloride, which is a type of medicine called a selective noradrenaline re-uptake inhibitor. It is a non-stimulant ...
Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of ...
Brand Name(s): Strattera ... Do not use atomoxetine if you have used an MAO inhibitor such as isocarboxazid ... thoughts or behavior while taking atomoxetine. ...
Atomoxetine affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. ... Do not use atomoxetine if you have used an MAO ...
Atomoxetine affects chemicals in the brain and nerves that contribute to ... Do not take atomoxetine if you have used an MAO inhibitor such as isocarboxazid ...
Benefits and potential side effects of Strattera (Atomoxetine) ... Atomoxetine, brand name, Strattera, was approved by the FDA for distribution in November 2002.
Strattera (atomoxetine HCl) ... Rarely, sudden unexplained death has been associated with atomoxetine use. ... shows that atomoxetine is effective in ...
Here is what users have to say about Atomoxetine

Strattera.jpg

Use

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Atomoxetine
Huffingtonpost.com
I have (rather acute) combined-type ADHD; "cannot tolerate" is just about the only way to describe atomoxetine. Though brief, that trial was without question the absolute worst experience I have ever had in my 24 years of life. I do not wan...
Medical News Today
The medications evaluated included OROS(R) methylphenidate, other methylphenidate formulations, non-methylphenidat estimulants, and non-stimulant atomoxetine. A review of this data found that OROS(R) methylphenidate had a lower frequency of...
Health 24
Della Bella noted the relatively new non-stimulant atomoxetine can also be effective for children who don't respond well to a stimulant. But it's not the initial medication of choice for ADHD, he said. "The upside of atomoxetine is that whe...
Times Online
... and teachers, the National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Mental Health (NCCMH) recommend. Drugs such as Ritalin and Concerta (brand names for methylphenidate) and Stratter...